Thomas McCourt's holdings in Ironwood Pharmaceuticals have seen significant changes over the years. His stock holdings peaked in 2021, surging to about $8 million. This growth reflects his responsive trading actions, with values fluctuating from $6 million to a peak...

$4.84M-48.54%

Nov 15, 2024

Stock Sold

$14.50M

IRWD

$14.50M

1,230,510 shares

What if they kept their stock?

If Thomas McCourt didn't sell their stock, today they would have:
Extra IRWD1,230,510 shares worth $5.18M.
This is -64.27% and $9.32M less than what they got when they sold the stock.
If they kept all their stock, their total holdings would be worth $10.02M.

Recent Insider Trades

IRWD

$436.14K

IRWD at $6.45/share

May 20, 2024

Sale

IRWD

264,876 shares

IRWD

Mar 5, 2024

Received

IRWD

$2.70M

IRWD at $15.24/share

Feb 12, 2024

Sale

IRWD

249,617 shares

IRWD

Jan 17, 2024

Received

IRWD

$284.96K

IRWD at $10.70/share

May 30, 2023

Sale

IRWD

$364.32K

IRWD at $10.12/share

May 22, 2023

Sale

IRWD

$224.59K

IRWD at $10.62/share

May 8, 2023

Sale

IRWD

$492.20K

IRWD at $10.67/share

Mar 27, 2023

Sale

IRWD

240,595 shares

IRWD

Mar 8, 2023

Received

IRWD

$378.74K

IRWD at $11.22/share

Mar 3, 2023

Sale

Thomas McCourt

Ex-CEO of Pliant Therapeutics

TM

View Compensation History

2023 Total Compensation

$4.58M

Salary

$833.67K

Bonus

$750.78K

Stock

$2.97M

Other

$24.57K